About TUDORZA® PRESSAIR®

(aclidinium bromide inhalation powder)

Use twice a day for the maintenance treatment of COPD1

Why TUDORZA® PRESSAIR®?

TUDORZA PRESSAIR is an anticholinergic indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD). Note: TUDORZA PRESSAIR is not indicated for the initial treatment of acute episodes of bronchospasm (i.e. rescue therapy).1

Reassuring Dual Feedback

Prescribe with confidence. PRESSAIR is the only preloaded dry powder inhaler that provides reassuring feedback in two ways* each time patients inhale their dose correctly.1 

A “click” will sound when the patient is inhaling correctly

The control window changes from GREEN to RED when a patient has successfully inhaled the full dose

TUDORZA PRESSAIR inhaler with label

*Feedback mechanisms consist of visual cues (color-controlled window) and an audible “click.” Note: some people may not hear the "click." Use the control window to ensure you have inhaled correctly.

REFERENCES: 1. Tudorza® Pressair® (aclidinium bromide inhalation powder) [prescribing information]. Covis Pharma GmbH and Zug, Switzerland, August 2022 .